Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
T(H)17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL-17 and IL-22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, T(H)17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4+ lymphocyte recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [128]
The cited source says what the claim attributes to it.
In the citing paper
“a subset of CD4+ T cells that is a major contributor to the pathogenicity of several inflammatory and autoimmune conditions (9–11)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“inflammatory subtypes of T cells, particularly Th17 cells, are clearly deleterious in diseases such as multiple sclerosis (9–11, 24)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Th17 cells are deleterious to the CNS”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 259
Self-citationExpression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes
Chung, Y., Yang, X., Chang, S. H., Ma, L., Tian, Q., & Dong, C. (2006) · Cell Research · doi:10.1038/sj.cr.7310106 · Cited by 231
Cited by
Items 401–500 of 1,003
Jha, M. K., Minhajuddin, A., Gadad, B. S., Greer, T. L., Mayes, T. L., & Trivedi, M. H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.07.005 · Cited by 79
Darlington, P. J., Stopnicki, B., Touil, T., Doucet, J.-S., Fawaz, L. M., Roberts, M. E., Boivin, M., Arbour, N., Freedman, M. S., Atkins, H. L., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00834 · Cited by 82
“These cells, including those co-expressing IL-17 and IFN-γ, have the capacity to disrupt the blood–brain barrier and directly injure neurons, and therefore have been of particular interest in the study of MS (2, 3).”
BackgroundSelf-citationCommon Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease
Rossi, B., Santos-Lima, B., Terrabuio, E., Zenaro, E., & Constantin, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639369 · Cited by 91
“Following CNS invasion, Th1 and Th17 cells produce inflammatory mediators and cytokines to establish and/or maintain an inflammatory environment that promotes neuronal loss, a common feature of MS and AD that positively correlates with the disease course (167, 168).”
BackgroundHahn, J. N., Falck, V., & Jirik, F. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45114 · Cited by 86
“In addition, Th17 cells have also been shown to express GB (35, 36).”
BackgroundNeuroactive steroids, their metabolites, and neuroinflammation
Giatti, S., Boraso, M., Melcangi, R. C., & Viviani, B. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0127 · Cited by 78
Saresella, M., Piancone, F., Tortorella, P., Marventano, I., Gatti, A. V., Caputo, D., Lunetta, C., Corbo, M., Rovaris, M., & Clerici, M. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.04.010 · Cited by 89
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months
Mercanti, S. F. D., Rolla, S., Cucci, A., Bardina, V., Cocco, E. E., Vladić, A., Soldo-Butković, S., Habek, M., Adamec, I., Horáková, D., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000194 · Cited by 81
“Th17 and Th1/17 cells (an intermediate subset producing interleukin [IL]–17 and IFN-g(7)) are increased in the peripheral blood (PB) and CSF at the time of a new relapse(8) and cross the blood–brain barrier (BBB) more easily than Th1 cells.(9) Some reports have examined(10,11) the CD19, CD4, and CD8 subsets and relate…”
BackgroundXiao, X., Shi, X., Fan, Y., Wu, C., Zhang, X., Minze, L. J., Liu, W., Ghobrial, R. M., Lan, P., & Li, X. C. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.013 · Cited by 79
“, 2007), multiple sclerosis (Kebir et al., 2007), and psoriasis (Ma et al.”
The Blood–Brain Barrier: Composition, Properties, and Roles in Brain Health
Lacoste, B., Prat, A., Andrade, M. F., & Gu, C. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041422 · Cited by 94
Self-citationExpanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System
Pilli, D., Zou, A., Tea, F., Dale, R. C., & Brilot, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00652 · Cited by 82
“The high expression of granzyme B by myelin-specific Th17 cells also promotes the death of human neurons (94).”
BackgroundFabrazzo, M., Cipolla, S., Signoriello, S., Camerlengo, A., Calabrese, G., Giordano, G. M., Argenziano, G., & Galderisi, S. (2021) · European Psychiatry · doi:10.1192/j.eurpsy.2021.2249 · Cited by 86
“The interactive communication between the neuroendocrine and immune systems may be partly mediated by serotonin, which is involved in the physiological functions of the skin through its receptors [70,71].”
BackgroundRole of osteopontin in synovial Th17 differentiation in rheumatoid arthritis
Chen, G., Zhang, X., Li, R., Fang, L., Niu, X., Zheng, Y., He, D., Xu, R., & Zhang, J. Z. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27603 · Cited by 78
Kan, A. A., de Jager, W., de Wit, M., Heijnen, C., van Zuiden, M., Ferrier, C., van Rijen, P., Gosselaar, P., Hessel, E., van Nieuwenhuizen, O., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-207 · Cited by 76
Paroni, M., Maltese, V., De Simone, M., Ranzani, V., Larghi, P., Fenoglio, C., Pietroboni, A. M., De Riz, M. A., Crosti, M. C., Maglie, S., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.11.045 · Cited by 77
Fragoulis, A., Siegl, S., Fendt, M., Jansen, S., Soppa, U., Brandenburg, L., Pufe, T., Weis, J., & Wruck, C. J. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.024 · Cited by 77
“This process facilitates further infiltration of leukocytes and Th17 cells into the brain, further amplifying the neuroinflammatory process [26].”
BackgroundIL-22 Binding Protein (IL-22BP) in the Regulation of IL-22 Biology
Zenewicz, L. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766586 · Cited by 83
“In the inflamed CNS, IL-22 has been proposed to aid in blood brain barrier disruption (62), yet also have a role in mediating protection of CNS barrier integrity (63).”
BackgroundThe Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update
Sangha, A., Quon, M., Pfeffer, G., & Orton, S. M. (2023) · Nutrients · doi:10.3390/nu15132978 · Cited by 87
“Reactive astrocytes also play a role in BBB instability [120,125,126].”
BackgroundNyirenda, M. H., Morandi, E., Vinkemeier, U., Constantin‐Teodosiu, D., Drinkwater, S., Mee, M., King, L. D. W., Podda, G., Zhang, G., Ghaemmaghami, A. M., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1400472 · Cited by 78
“5, 9) have the capacity to cross the blood–cerebrospinal fluid barrier (19) and, therefore, could infiltrate the CNS and initiate tissue-specific inflammatory damage.”
BackgroundWon, H. Y., Sohn, J.-H., Min, H. J., Lee, K., Woo, H. A., Ho, Y.-S., Park, J., Rhee, S.-G., & Hwang, E. S. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2989 · Cited by 77
“Th17 cells secrete IL-17 and have been found to contribute to autoimmune disorders such as arthritis (2, 19), Crohn’s disease (42, 43), ulcerative colitis (25), psoriasis (39), and multiple sclerosis (23).”
Interaction of astrocytes and T cells in physiological and pathological conditions
Xie, L., & Yang, S. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.026 · Cited by 91
Laurenčikas, E., Gavhed, D., Stålemark, H., Hooft, I. V., Prayer, D., Grois, N., & Henter, J. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22791 · Cited by 79
“This assumption may be supported by the recent report on the potential role of IL-17A in LCH, and the evidence that TH17 lymphocytes that synthesize IL-17A may promote BBB disruption [5,39].”
BackgroundResultGene Expression Profiling in Autoimmune Noninfectious Uveitis Disease
Li, Z., Liu, B., Maminishkis, A., Mahesh, S. P., Yeh, S., Lew, J. C., Lim, W. K., Sen, H. N., Clarke, G., Buggage, R. R., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5147 · Cited by 79
“Similar to what has been demonstrated in multiple sclerosis that IL-22 affects the blood-brain barrier (30), IL-22 may disrupt the blood-retina barrier by reducing RPE total epithelial resistance (TER) and inducing RPE apoptosis.”
BackgroundResultZimmermann, J., Krauthausen, M., Hofer, M. J., Heneka, M. T., Campbell, I. L., & Müller, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057307 · Cited by 75
“Astrocytes have been shown to constitutively express the IL-17 receptor, allowing a direct effect of IL-17A on astrocytes [38].”
BackgroundLiu, R., Ma, X., Chen, L., Yang, Y., Zeng, Y., Gao, J., Jiang, W., Zhang, F., Li, D., Han, B., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601727 · Cited by 77
“Patients with a history of additional CNS diseases, tumor or systemic hematologic diseases, or infections were excluded.”
BackgroundInfluentialElevated CNS Inflammation in Patients with Preclinical Alzheimer's Disease
Monson, N. L., Ireland, S. J., Ligocki, A. J., Chen, D., Rounds, W. H., Li, M., Huebinger, R. M., Munro Cullum, C., Greenberg, B. M., Stowe, A. M., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.183 · Cited by 76
Tarlinton, R. E., Хайбуллин, Т. И., Granatov, E. V., Martynova, E. V., Rizvanov, A. A., & Khaiboullina, S. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020303 · Cited by 91
Yang, D., Sun, Y., Bhaumik, S. K., Li, Y., Baumann, J. M., Lin, X., Zhang, Y., Lin, S.-H., Dunn, R. S., Liu, C., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2582-14.2014 · Cited by 77
“…after LPS/HI injury In experimental autoimmune encephalomyelitis (EAE), TH17 cells enter the CNS initially through the choroid plexus and secondarily in the leptomeningeal space after substantial brain damage and opening of the BBB (Ransohoff et al., 2003; Kebir et al., 2007; Reboldi et al., 2009).”
BackgroundLiu, X., Yang, P., Lin, X., Ren, X., Zhou, H., Huang, X., Chi, W., Kijlstra, A., & Chen, L. (2009) · Clinical Immunology · doi:10.1016/j.clim.2008.12.007 · Cited by 78
Wang, D., Zhao, Y.-F., Wang, G., Sun, B., Kong, Q., Zhao, K., Zhang, Y., Wang, J., Liu, Y., Mu, L., et al. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.04.007 · Cited by 78
“The observation that Th17 lymphocytes transmigrate across the blood brain barrier and kill neurons by secreting granzyme B suggests that IL-17 could influence stroke-mediated pathology in the brain (Kebir et al., 2007).”
BackgroundInfluentialGaskill, P. J., Calderon, T. M., Coley, J. S., & Berman, J. W. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9443-y · Cited by 79
“Th17 cells were shown to alter tight junction expression and disrupt the BBB, resulting in their transmigration into the CNS. Th17 cell localization within the CNS resulted in damage to neurons and increased neuroinflammation through CD4+ T cell recruitment (Kebir et al. 2007; Huppert et al. 2010).”
Multiple Sclerosis: New Insights in Pathogenesis and Novel Therapeutics
Ontaneda, D., Hyland, M. H., & Cohen, J. A. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042910-135833 · Cited by 96
Chen, S., Liu, Y., Niu, Y., Xu, Y., Zhou, Q., Xu, X., Wang, J., & Yu, M. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.03.045 · Cited by 83
Th17 cell pathogenicity in autoimmune disease
Park, E., & Ciofani, M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01535-9 · Cited by 75
Lyck, R., Lécuyer, M.-A., Abadier, M., Wyss, C. B., Matti, C., Rosito, M., Enzmann, G., Zeis, T., Michel, L., García Martín, A. B., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16678639 · Cited by 75
“Th1 and Th17 cells used for this experiment were generated by in vitro polarization of ex vivo human CD4þCD45ROþ T cells as described.(31) These T cells expressed similar cell surface levels of CD6 but lower cell surface levels of ALCAM when compared to ex vivo sorted Th1 cells (Supplementary Figure 2).”
MethodSelf-citationAutoimmune and inflammatory mechanisms of CNS damage
Kapadia, M., & Šakić, B. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.008 · Cited by 81
“through the production of ROS within endothelial cells, ultimately resulting in down regulation of tight junction molecules (Huppert et al., 2010; Kebir et al., 2007).”
BackgroundBeyeen, A. D., Adzemovic, M. Z., Öckinger, J., Stridh, P., Bečanović, K., Lindahl, H., Lassmann, H., Harris, R. A., Hillert, J. A., Alfredsson, L. S., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001392 · Cited by 80
“IL-22RA1 mediates breakage of the blood–brain barrier in MS patients and is also a risk gene for chronic rhinosinusitis (44, 45).”
BackgroundLiu, X., Zhou, F., Yang, Y., Wang, W., Niu, L., Zuo, D., Li, X., Hua, H., Zhang, B., Kou, Y., et al. (2018) · Glia · doi:10.1002/glia.23530 · Cited by 83
Parodi-Rullán, R. M., Javadov, S., & Fossati, S. (2021) · Cells · doi:10.3390/cells10112903 · Cited by 73
“The infiltration of neutrophils also triggers the release of IL-17 [24], which increases BBB permeability [157,158].”
BackgroundBlood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis
Errede, M., Girolamo, F., Ferrara, G., Strippoli, M., Morando, S., Boldrin, V., Rizzi, M., Uccelli, A., Perris, R., Bendotti, C., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31826ac110 · Cited by 75
Cholinergic Modulation of the Immune System in Neuroinflammatory Diseases
Reale, M., & Costantini, E. (2021) · Diseases · doi:10.3390/diseases9020029 · Cited by 82
“Th1 and Th17 CD4+ T cells infiltrate both the white and gray matter of MS or AD patients, producing inflammatory mediators involved in neuronal loss, that positively correlate with the disease course [57].”
BackgroundCD4 + T cells aggravate hemorrhagic brain injury
Shi, S. X.-Y., Xiu, Y., Li, Y., Yuan, M., Shi, K., Liu, Q., Wang, X., & Jin, W.-N. (2023) · Science Advances · doi:10.1126/sciadv.abq0712 · Cited by 83
“IL-17 has known proinflammatory functions, which initiate and drive inflammation in a tissue-dependent manner in response to injury or infection ( 19 – 21 ).”
Brucklacher-Waldert, V., Steinbach, K., Lioznov, M. V., Kolster, M., Hölscher, C., & Tolosa, E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901000 · Cited by 88
Sénécal, V., Deblois, G., Beauseigle, D., Schneider, R., Brandenburg, J., Newcombe, J., Moore, C. S., Prat, A., Antel, J. P., & Arbour, N. (2015) · Glia · doi:10.1002/glia.22948 · Cited by 74
“IL-27 can dampen the capacity of human T lymphocytes to produce cytokines that have been implicated in the pathogenesis of MS (Codarri et al., 2013; Kebir et al., 2007, 2009): IL-17, IL-22, and GM-CSF (Liu and Rohowsky-Kochan, 2011; Young et al., 2012).”
Self-citationPeripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease
Kuštrimović, N. Z., Marino, F., & Cosentino, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181009161048 · Cited by 77
Wen, J., Ribeiro, R., Tanaka, M., & Zhang, Y. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.010 · Cited by 87
Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis
Kulcsar, K. A., Baxter, V. K., Greene, I. P., & Griffin, D. E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418966111 · Cited by 78
“Granzyme B induces neurotoxicity by activation of protease-activated G protein-coupled receptors on neurons (43), and both granzyme B and IL-22 contribute to blood–brain barrier disruption (44).”
BackgroundChen, J., Cascio, J. A., Magee, J., Techasintana, P., Gubin, M. M., Dahm, G. M., Calaluce, R., Yu, S., & Atasoy, U. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301188 · Cited by 81
“Another study showed that human Th17-differentiated cells could more effectively traverse the blood–brain barrier endothelial cells than Th1-differentiated cells (39).”
BackgroundIL‐23‐driven encephalo‐tropism and Th17 polarization during CNS‐inflammation in vivo
Gyülvészi, G., Haak, S., & Becher, B. (2009) · European Journal of Immunology · doi:10.1002/eji.200939305 · Cited by 82
Self-citationUncovering the pathogenesis of large granular lymphocytic leukemia—novel STAT3 and STAT5b mutations
Rajala, H. L. M., Porkka, K., Maciejewski, J. P., Loughran, T. P., & Mustjoki, S. M. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.882105 · Cited by 78
Regulation and function of IL-17A- and IL-22-producing γδ T cells
Ness-Schwickerath, K. J., & Morita, C. T. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0700-z · Cited by 91
Nanotherapeutic systems for local treatment of brain tumors
Chakroun, R. W., Zhang, P., Lin, R., Schiapparelli, P. V., Quiñones‐Hinojosa, A., & Cui, H. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1479 · Cited by 83
Interleukin-4 as a therapeutic target
Gärtner, Y., Bitar, L., Zipp, F., & Vogelaar, C. F. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108348 · Cited by 76
Larochelle, C., Lécuyer, M., Alvarez, J. I., Charabati, M., Saint‐Laurent, O., Ghannam, S., Kebir, H., Flanagan, K., Yednock, T., Duquette, P., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24415 · Cited by 73
“nonepileptic surgical human CNS material as previously published.(21,23,24) Informed consent was obtained from every donor”
MethodSelf-citationActivation of Myeloid TLR4 Mediates T Lymphocyte Polarization after Traumatic Brain Injury
Braun, M., Vaibhav, K., Saad, N., Fatima, S., Brann, D. W., Vender, J. R., Wang, L. P., Hoda, M. N., Baban, B., & Dhandapani, K. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601948 · Cited by 77
“In addition to central regulation, TH17 cells migrated across the BBB to exacerbate CNS inflammation via activation of IL-17 and IL-22 receptors on BBB endothelial cells (56).”
BackgroundAdvances in the study of IL-17 in neurological diseases and mental disorders
Lu, Y., Zhang, P., Xu, F., Zheng, Y., & Zhao, H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1284304 · Cited by 82
“As early as 2007, research conducted on the animal model of MS, EAE mice, revealed that IL-17 induces BBB damage (148).”
BackgroundRoles of Cytokines in Alzheimer’s Disease
Chen, Z., Balachandran, Y. L., Chong, W. P., & Chan, K. W. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115803 · Cited by 81
“In neuroinflammation, IL-17 contributes to disrupting the BBB and encourages inflammation in the CNS [30].”
BackgroundNakatsuji, Y., Okuno, T., Moriya, M., Sugimoto, T., Kinoshita, M., Takamatsu, H., Nojima, S., Kimura, T., Kang, S., Ito, D., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102023 · Cited by 76
“In addition, Th17 cells have been shown to enhance CNS inflammation by inducing the expression of inflammatory chemokines and IL-6 in astrocytes (39–41).”
BackgroundInfluentialFingolimod for Multiple Sclerosis: Mechanism of Action, Clinical Outcomes, and Future Directions
Mehling, M., Kappos, L., & Derfuss, T. J. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0216-9 · Cited by 74
“In MS lesions, Th17 cells are detected in high numbers and have an enhanced capacity to kill human neuronal cells when compared with control Tcells [25, 26 ].”
BackgroundIL-22 Signaling Contributes to West Nile Encephalitis Pathogenesis
Wang, P., Bai, F., Zenewicz, L. A., Dai, J., Gate, D., Cheng, G., Yang, L., Qian, F., Yuan, X., Montgomery, R. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044153 · Cited by 73
“IL-22 contributes to pathogenesis of psoriasis by inducing the proinflammatory S100 family of calcium binding proteins [5,7] and plays a role in multiple sclerosis by promoting leukocyte infiltration into the brain [14].”
BackgroundMethodMartín, R., Hernández, M., Córdova, C., & Nieto, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01869.x · Cited by 70
“In addition, as it has been recently demonstrated that Th17 cytokines impair BBB integrity by disrupting tight junctions (Kebir et al., 2007), we examined whether triterpene treatment affected the expression levels of the major Th17 cytokine, IL-17A.”
BackgroundSaresella, M., Marventano, I., Longhi, R., Lissoni, F., Trabattoni, D., Mendozzi, L., Caputo, D., & Clerici, M. (2008) · The FASEB Journal · doi:10.1096/fj.08-110650 · Cited by 72
“Molecular mimicry with cross-reacting and yet undefined epitopes is likely to be the initial trigger (13, 14), leading to the activation of CD4 TH1 lymphocytes, TH17 cells, CD8 T lymphocytes, and B lymphocytes as well as myeloid dendritic cells (15, 16).”
BackgroundRegulation of the neurodegenerative process associated to Parkinson's disease by CD4+ T-cells
González, H., Contreras, F., & Pacheco, R. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9618-9 · Cited by 70
Zhang, X., Kiapour, N., Kapoor, S., Khan, T. H., Thamilarasan, M., Tao, Y., Cohen, S. M., Miller, C. R., Sobel, R. A., & Markovic‐Plese, S. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900311 · Cited by 77
“Finally, Th17 cell migration across the BBB-EC monolayer via IL-17R and IL-22R signaling is mediated via the disruption of tight junction proteins (29).”
BackgroundCrome, S. Q., Wang, A. Y., Kang, C. Y., & Levings, M. K. (2009) · European Journal of Immunology · doi:10.1002/eji.200838908 · Cited by 70
Participation of interleukin 17A in neuroimmune interactions
Moynes, D. M., Vanner, S. J., & Lomax, A. E. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.03.004 · Cited by 74
Protective and Pathological Properties of IL-22 in Liver Disease
Cobleigh, M. A., & Robek, M. D. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.08.043 · Cited by 70
Dagur, P. K., Biancotto, A., Wei, L., Nida Sen, H., Yao, M., Strober, W., Nussenblatt, R. B., & Philip McCoy, J. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.09.003 · Cited by 69
“IL-17A has been demonstrated to induce blood barrier disruption by direct action on endothelial cells [30], possibly facilitating the migration of Th17 cells through the endothelial barrier [16].”
Backgroundγδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis
Blink, S. E., Caldis, M. W., Goings, G. E., Harp, C. T., MALISSEN, B., Prinz, I., Xu, D., & Miller, S. D. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.04.013 · Cited by 77
“IL-17 can act directly on stromal cells to produce inflammation and MS, and has been suggested to potentiate the migration of lymphocytes across the blood brain barrier [50; 51].”
Geginat, J., Paroni, M., Pagani, M., Galimberti, D., Francesco, R. D., Scarpini, E. A., & Abrignani, S. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.04.006 · Cited by 81
“IL-17 can enhance BBB permeability [100] and has neurotoxic potential [101]; in addition, promising results were obtained in a clinical trial with a neutralizing anti-IL-17 antibody in RR-MS [102].”
Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications
Lee, D. K., & Song, S. U. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.08.009 · Cited by 77
“Central nerve system-related studies have found that both Th1 and interleukin-17A-secreting CD4 (Th17) lymphocytes are involved in the pathogenesis of multiple sclerosis (MS) and one of the best animal models of EAE in mice [102-104].”
BackgroundThe Ins and Outs of Central Nervous System Inflammation—Lessons Learned from Multiple Sclerosis
Ramaglia, V., Rojas, O. L., Naouar, I., & Gommerman, J. L. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-124155 · Cited by 79
Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammation
Larochelle, C., Wasser, B., Jamann, H., Löffel, J. T., Cui, Q., Tastet, O., Schillner, M., Luchtman, D. W., Birkenstock, J., Stroh, A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025813118 · Cited by 73
“The capacity of IL-23 – skewed Th17 cells to destabilize the blood – brain barrier (BBB) and recruit antigen-presenting cells to the CNS compartment in neuroinflammation is well established (13, 19, 20), but it is not clear whether Th17 cells cause tissue injury themselves.”
Cao, L., Wang, H., Wang, F., Xu, D., Liu, F., & Liu, C. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11612 · Cited by 70
Cyclooxygenase-2 Regulates Th17 Cell Differentiation during Allergic Lung Inflammation
Li, H., Bradbury, J. A., Dackor, R. T., Edin, M. L., Graves, J. P., DeGraff, L. M., Wang, P. M., Bortner, C. D., Maruoka, S., Lih, F. B., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1637oc · Cited by 71
Holley, J. E., Bremer, E., Kendall, A. C., de Bruyn, M., Helfrich, W., Tarr, J. M., Newcombe, J., Gutowski, N. J., & Eggleton, P. (2014) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2014.06.001 · Cited by 71
“Mounting evidence supports a role for Th17 cells in MS autoimmunity, relapse, and neuronal and blood-brainbarrier (BBB) damage in patients and murine MS models (Harrington et al., 2005; Kebir et al., 2007).”
BackgroundStravitz, R. T., Sanyal, A. J., Reisch, J., Bajaj, J. S., Mirshahi, F., Cheng, J., Lee, W. M., & The Acute Liver Failure Study Group (2013) · Liver International · doi:10.1111/liv.12214 · Cited by 69
“, cytokines) and T-lymphocytes (23), providing one plausible link between IL-17 levels and encephalopathy progression in this study.”
BackgroundWebb, L., Amici, S. A., Jablonski, K., Savardekar, H., Panfil, A. R., Li, L., Zhou, W., Peine, K. J., Karkhanis, V. A., Bachelder, E. M., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601702 · Cited by 70
“MS is associated with increased Th1 and Th17 inflammatory responses (9) and deficient Th2 and regulatory T cell responses (10).”
BackgroundCamelo, S. (2014) · Autoimmune Diseases · doi:10.1155/2014/532487 · Cited by 76
“Moreover, in experimental autoimmune encephalitis, a model of multiple sclerosis, it has been observed that IL-17 is able to breach tight junction of the blood-brain barrier in vivo [92].”
BackgroundSerum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis
Chen, Y.-C., Chen, S., Miao, L., Liu, Z., Li, W., Zhao, Z., Sun, X., Jiang, G., & Cheng, Q. H. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.12.008 · Cited by 73
The biocontaminants and complexity of damp indoor spaces: more than what meets the eyes
Thrasher, J. D., & Crawley, S. (2009) · Toxicology and Industrial Health · doi:10.1177/0748233709348386 · Cited by 83
“Human Th-17 cells promote disruption of blood–brain barrier tight junctions, promote CNS inflammation and kill human neurons through recruitment of CD4þ lymphocytes (Kebir et al., 2007).”
BackgroundRigor, R. R., Beard, R. S., Litovka, O. P., & Yuan, S. Y. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00371.2011 · Cited by 67
“This was in sharp contrast to studies by other investigators (23, 24) showing that exposure to the cytokine IL-17 caused BBB dysfunction coupled with decreased expression of occludin and ZO-1.”
ResultTH17 cells express ST2 and are controlled by the alarmin IL-33 in the small intestine
Reguant, A. P., Bayat‐Sarmadi, J., Baumann, C., Noster, R., Cirera‐Salinas, D., Curato, C., Pelczar, P., Huber, S., Zielinski, C. E., Löhning, M., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.5 · Cited by 69
Michel, L., Grasmuck, C., Charabati, M., Lécuyer, M., Zandee, S., Dhaeze, T., Alvarez, J. I., Li, R., Larouche, S., Bourbonnière, L., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw0475 · Cited by 73
Self-citationKihara, Y., Yokomizo, T., Kunita, A., Morishita, Y., Fukayama, M., Ishii, S., & Shimizu, T. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.049 · Cited by 66
Anti-Selectin Therapy for the Treatment of Inflammatory Diseases
Rossi, B., & Constantin, G. (2008) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152808785107633 · Cited by 68
Carrillo-Salinas, F. J., Navarrete, C., Mecha, M., Feliú, A., Collado, J. A., Cantarero, I., Bellido, M. L., Muñoz, E., & Guaza, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094733 · Cited by 66
“Phytocannabinoids that do not produce psychotropic effects are considered of special interest as novel therapeutic agents in CNS diseases.”
BackgroundInfluentialAstrocytes to the rescue! Glia limitans astrocytic endfeet control CNS inflammation
Quintana, F. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95769 · Cited by 67
“For example, although Horng et al. report that IL-17 does not affect the expression of tight junction proteins, it is possible that other cytokines secreted by Th17 cells may modulate the barrier function of the glia limitans, as previously reported for the BBB (21).”
Distinct characteristics of hippocampal pathogenic th17 cells in a mouse model of depression
Beurel, E., Lowell, J. A., & Jope, R. S. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.04.012 · Cited by 65
Dolff, S., Quandt, D., Wilde, B., Feldkamp, T., Hua, F., Cai, X., Specker, C., Kribben, A., Kallenberg, C. G. M., & Witzke, O. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3100 · Cited by 69
“There is increasing evidence that IL-17-producing T-cells play an important role in various autoimmune diseases including multiple sclerosis, psoriasis, rheumatoid arthritis, inflammatory bowel disease, ANCA associated vasculitis and systemic lupus erythematosus [7-11].”
BackgroundÁlvarez‐Sánchez, N., Cruz‐Chamorro, I., Díaz‐Sánchez, M., Sarmiento‐Soto, H., Medrano‐Campillo, P., Martínez‐López, A., Lardone, P. J., Guerrero, J. M., & Carrillo‐Vico, A. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12442 · Cited by 68
Yi, W., Schlüter, D., & Wang, X. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.05.029 · Cited by 72
Ouédraogo, O., Rébillard, R., Jamann, H., Mamane, V. H., Clénet, M., Daigneault, A., Lahav, B., Uphaus, T., Steffen, F., Bittner, S., et al. (2020) · Epilepsia · doi:10.1111/epi.16742 · Cited by 66
“Duration of epilepsy, median y (range) NA 12 (1-37) 16 (2-46) .”
BackgroundSelf-citationLoos, J., Schmaul, S., Noll, T. M., Paterka, M., Schillner, M., Löffel, J. T., Zipp, F., & Bittner, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02021-x · Cited by 78
Ishii, H., Tanabe, S., Ueno, M., Kubo, T., Kayama, H., Serada, S., Fujimoto, M., Takeda, K., Naka, T., & Yamashita, T. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.234 · Cited by 64
Neuromyelitis Optica and Asian Phenotype of Multiple Sclerosis
Kira, J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1444.002 · Cited by 67
Shamji, M. F., Allen, K. D., So, S., Jing, L., Adams, S. B., Schuh, R., Huebner, J. L., Kraus, V. B., Friedman, A. H., Setton, L. A., et al. (2009) · Spine · doi:10.1097/brs.0b013e318197f013 · Cited by 66
D’Aversa, T. G., Eugenín, E. A., Lopez, L., & Berman, J. W. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01279.x · Cited by 72
Vollmer, T. L., Wynn, D. R., Alam, M. S., & Valdes, J. M. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510384496 · Cited by 65
“Taken together, both the clinical and animal model data suggest that IL-12 and IL-23 and their downstream targets play a pivotal role in the pathogenesis of MS.(10,11) Currently, numerous pharmacologic agents are being investigated for their ability to ameliorate autoimmune diseases, including MS, by inhibiting signal…”
BackgroundResultImmune Regulation of Antibody Access to Neuronal Tissues
Iwasaki, A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.01.004 · Cited by 72
“The opening of the BBB and BNB for antibody access requires entry of antigen-specific CD4+ T cells and induction of vascular permeability upon secretion of cytokines such as IFN-γ or IL-17A.”
Ohara, D., Takeuchi, Y., & Hirota, K. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01218-x · Cited by 74
“…within active MS brain lesions crossing the BBB, alongside the positive correlation between IL-17A production by myelin basic protein-primed CD4 + T cells from peripheral blood mononuclear cells (PBMCs) and disease activity, has implicated type 17 immunity in the pathogenesis of MS [174 – 176].”
Background
Metadata
- Authors
- Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A.
- Affiliations
- University of Zurich (CH)
- Hôpital Notre-Dame (CA)
- University of Alberta (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- Nature Medicine
- Published
- 2007-09-09
- Volume
- 13
- Issue
- 10
- Pages
- 1173-1175
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC5114125
- OpenAlex
- W1998000193
- Semantic Scholar
- d0c491686d390e0dfdffedd4e32222d5b6065fd7
- Cited by
- 1,759
- References
- 14
- Citations by year
- 2026: 69 · 2025: 78 · 2024: 85 · 2023: 116 · 2022: 104 · 2021: 86 · 2020: 96 · 2019: 87 · 2018: 98 · 2017: 98 · 2016: 90 · 2015: 94 · 2014: 97 · 2013: 106 · 2012: 86
- FWCI
- 54.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (79785_1)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Th17 cells, blood-brain barrier, endothelial cells, IL-17, IL-22, tight junctions, multiple sclerosis, neuroinflammation, lymphocyte transmigration, granzyme B
- MeSH terms
- Blood-Brain Barrier, Cell Membrane Permeability, Cell Movement, Cells, Cultured, Central Nervous System, Dose-Response Relationship, Drug, Endothelium, Vascular, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Multiple Sclerosis, CD4-Positive T-Lymphocytes, Case-Control Studies, Receptors, Interleukin, Tight Junctions, Interleukin-17, Endothelial Cells, Granzymes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.